76 related articles for article (PubMed ID: 10328268)
1. Major subdomain rearrangement in HIV-1 reverse transcriptase simulated by molecular dynamics.
Madrid M; Jacobo-Molina A; Ding J; Arnold E
Proteins; 1999 May; 35(3):332-7. PubMed ID: 10328268
[TBL] [Abstract][Full Text] [Related]
2. Collective motions in HIV-1 reverse transcriptase: examination of flexibility and enzyme function.
Bahar I; Erman B; Jernigan RL; Atilgan AR; Covell DG
J Mol Biol; 1999 Jan; 285(3):1023-37. PubMed ID: 9887265
[TBL] [Abstract][Full Text] [Related]
3. Structure of unliganded HIV-1 reverse transcriptase at 2.7 A resolution: implications of conformational changes for polymerization and inhibition mechanisms.
Hsiou Y; Ding J; Das K; Clark AD; Hughes SH; Arnold E
Structure; 1996 Jul; 4(7):853-60. PubMed ID: 8805568
[TBL] [Abstract][Full Text] [Related]
4. Temperature-dependent equilibrium between the open and closed conformation of the p66 subunit of HIV-1 reverse transcriptase revealed by site-directed spin labelling.
Kensch O; Restle T; Wöhrl BM; Goody RS; Steinhoff HJ
J Mol Biol; 2000 Aug; 301(4):1029-39. PubMed ID: 10966802
[TBL] [Abstract][Full Text] [Related]
5. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits.
Sevilya Z; Loya S; Hughes SH; Hizi A
J Mol Biol; 2001 Aug; 311(5):957-71. PubMed ID: 11531332
[TBL] [Abstract][Full Text] [Related]
6. Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors.
Ren J; Nichols C; Bird L; Chamberlain P; Weaver K; Short S; Stuart DI; Stammers DK
J Mol Biol; 2001 Sep; 312(4):795-805. PubMed ID: 11575933
[TBL] [Abstract][Full Text] [Related]
7. p66 Trp24 and Phe61 are essential for accurate association of HIV-1 reverse transcriptase with primer/template.
Agopian A; Depollier J; Lionne C; Divita G
J Mol Biol; 2007 Oct; 373(1):127-40. PubMed ID: 17804012
[TBL] [Abstract][Full Text] [Related]
8. Thumbs down for HIV: domain level rearrangements do occur in the NNRTI-bound HIV-1 reverse transcriptase.
Wright DW; Sadiq SK; De Fabritiis G; Coveney PV
J Am Chem Soc; 2012 Aug; 134(31):12885-8. PubMed ID: 22827470
[TBL] [Abstract][Full Text] [Related]
9. Identification of specific HIV-1 reverse transcriptase contacts to the viral RNA:tRNA complex by mass spectrometry and a primary amine selective reagent.
Kvaratskhelia M; Miller JT; Budihas SR; Pannell LK; Le Grice SF
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15988-93. PubMed ID: 12461175
[TBL] [Abstract][Full Text] [Related]
10. NMR structure of the HIV-1 reverse transcriptase thumb subdomain.
Sharaf NG; Brereton AE; Byeon IL; Karplus PA; Gronenborn AM
J Biomol NMR; 2016 Dec; 66(4):273-280. PubMed ID: 27858311
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitors targeting HIV-1 reverse transcriptase dimerization.
Grohmann D; Corradi V; Elbasyouny M; Baude A; Horenkamp F; Laufer SD; Manetti F; Botta M; Restle T
Chembiochem; 2008 Apr; 9(6):916-22. PubMed ID: 18318036
[TBL] [Abstract][Full Text] [Related]
12. Molecular dynamics of HIV-1 reverse transcriptase indicates increased flexibility upon DNA binding.
Madrid M; Lukin JA; Madura JD; Ding J; Arnold E
Proteins; 2001 Nov; 45(3):176-82. PubMed ID: 11599020
[TBL] [Abstract][Full Text] [Related]
13. Active site dynamics and combined quantum mechanics/molecular mechanics (QM/MM) modelling of a HIV-1 reverse transcriptase/DNA/dTTP complex.
Rungrotmongkol T; Mulholland AJ; Hannongbua S
J Mol Graph Model; 2007 Jul; 26(1):1-13. PubMed ID: 17046299
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of Phe160 within the "palm" subdomain of human immunodeficiency virus type 1 reverse transcriptase.
Gutiérrez-Rivas M; Ibáñez A; Martínez MA; Domingo E; Menéndez-Arias L
J Mol Biol; 1999 Jul; 290(3):615-25. PubMed ID: 10395818
[TBL] [Abstract][Full Text] [Related]
15. Cross-linking of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase to template-primer.
Peletskaya EN; Boyer PL; Kogon AA; Clark P; Kroth H; Sayer JM; Jerina DM; Hughes SH
J Virol; 2001 Oct; 75(19):9435-45. PubMed ID: 11533206
[TBL] [Abstract][Full Text] [Related]
16. Probing Conformational States of the Finger and Thumb Subdomains of HIV-1 Reverse Transcriptase Using Double Electron-Electron Resonance Electron Paramagnetic Resonance Spectroscopy.
Schmidt T; Tian L; Clore GM
Biochemistry; 2018 Feb; 57(5):489-493. PubMed ID: 29251492
[TBL] [Abstract][Full Text] [Related]
17. Bridge water mediates nevirapine binding to wild type and Y181C HIV-1 reverse transcriptase--evidence from molecular dynamics simulations and MM-PBSA calculations.
Treesuwan W; Hannongbua S
J Mol Graph Model; 2009; 27(8):921-9. PubMed ID: 19414275
[TBL] [Abstract][Full Text] [Related]
18. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.
Auwerx J; Van Nieuwenhove J; Rodríguez-Barrios F; de Castro S; Velázquez S; Ceccherini-Silberstein F; De Clercq E; Camarasa MJ; Perno CF; Gago F; Balzarini J
FEBS Lett; 2005 Apr; 579(11):2294-300. PubMed ID: 15848161
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into mechanisms of non-nucleoside drug resistance for HIV-1 reverse transcriptases mutated at codons 101 or 138.
Ren J; Nichols CE; Stamp A; Chamberlain PP; Ferris R; Weaver KL; Short SA; Stammers DK
FEBS J; 2006 Aug; 273(16):3850-60. PubMed ID: 16911530
[TBL] [Abstract][Full Text] [Related]
20. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK
J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
